Search research articles
Contact Us
Filters
Showing results (81-90 of 88) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 88 results.
Advances in Radiation Oncology
|
January 31, 2024
Stereotactic Radiosurgery in the Management of Brain Metastases: A Case-Based Radiosurgery Society Practice Guideline
Colton Ladbury, Michael Pennock, Tugba Yilmaz, et al.
Journal of Neurosurgery
|
October 23, 2010
Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article
John A Boockvar, Apostolos J Tsiouris, Christoph P Hofstetter, et al.
AJNR. American Journal of Neuroradiology
|
February 23, 2026
[68Ga]-DOTATATE PET SUV Reduction After Bevacizumab in High-Grade Meningioma: A Potential Treatment Response Biomarker
Kellen Vo Vu, Hannah G Otis, Andrew Brandmaier, et al.
Neuro-Oncology
|
March 30, 2024
[Ga68] DOTATATE PET/MRI-guided radiosurgical treatment planning and response assessment in meningiomas
Jana Ivanidze, Se Jung Chang, Arsalan Haghdel, et al.
AJNR. American Journal of Neuroradiology
|
April 11, 2024
DOTATATE PET/MR Imaging Differentiates Secondary-Progressive from de Novo World Health Organization Grade 3 Meningiomas
Joon Tae Kim, Se Jung Chris Chang, Arsalan Haghdel, et al.
European Journal of Radiology
|
October 18, 2024
[18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastases
Jana Ivanidze, Arman Sharbatdaran, Aliah McCalla, et al.
Neuro-Oncology Advances
|
January 7, 2026
Long-term outcomes of active surveillance after DOTATATE PET/MRI-confirmed gross total resection in WHO grade 2 meningioma
Jana Ivanidze, Kellen Vo Vu, Umberto Tosi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 22, 2012
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality
Roger Stupp, Eric T Wong, Andrew A Kanner, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 88) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 88 results.
Advances in Radiation Oncology
|
January 31, 2024
Stereotactic Radiosurgery in the Management of Brain Metastases: A Case-Based Radiosurgery Society Practice Guideline
Colton Ladbury, Michael Pennock, Tugba Yilmaz, et al.
Journal of Neurosurgery
|
October 23, 2010
Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article
John A Boockvar, Apostolos J Tsiouris, Christoph P Hofstetter, et al.
AJNR. American Journal of Neuroradiology
|
February 23, 2026
[68Ga]-DOTATATE PET SUV Reduction After Bevacizumab in High-Grade Meningioma: A Potential Treatment Response Biomarker
Kellen Vo Vu, Hannah G Otis, Andrew Brandmaier, et al.
Neuro-Oncology
|
March 30, 2024
[Ga68] DOTATATE PET/MRI-guided radiosurgical treatment planning and response assessment in meningiomas
Jana Ivanidze, Se Jung Chang, Arsalan Haghdel, et al.
AJNR. American Journal of Neuroradiology
|
April 11, 2024
DOTATATE PET/MR Imaging Differentiates Secondary-Progressive from de Novo World Health Organization Grade 3 Meningiomas
Joon Tae Kim, Se Jung Chris Chang, Arsalan Haghdel, et al.
European Journal of Radiology
|
October 18, 2024
[18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastases
Jana Ivanidze, Arman Sharbatdaran, Aliah McCalla, et al.
Neuro-Oncology Advances
|
January 7, 2026
Long-term outcomes of active surveillance after DOTATATE PET/MRI-confirmed gross total resection in WHO grade 2 meningioma
Jana Ivanidze, Kellen Vo Vu, Umberto Tosi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 22, 2012
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality
Roger Stupp, Eric T Wong, Andrew A Kanner, et al.
Page
of 9